Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
US FDA Still Fighting Problems With Pre-ANDA Meeting Requests
Oct 09 2019
•
By
Derrick Gingery
The FDA granted more pre-ANDA meetings for complex generics through the first nine months of FY 2019 than in all of FY 2018. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Product Reviews
More from Pink Sheet